Contineum Therapeutics, Inc. (CTNM) vs Alpha Teknova, Inc. (TKNO)
A side-by-side comparison of Contineum Therapeutics, Inc. and Alpha Teknova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTNM
Contineum Therapeutics, Inc.
$12.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TKNO
Alpha Teknova, Inc.
$8.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CTNM vs TKNO
growth of $100 · dividends reinvested · last 2yCTNM -17.4% (-9.1%/yr)TKNO +250.2% (+87.1%/yr)TKNO compounded faster over this window
CTNM TKNO
CTNM vs TKNO: by the numbers
- •CTNM is the larger company ($476M vs $469M market cap).
- •Both run net losses; CTNM's is the smaller (0.00% vs -38.37% net margin).
Metrics side by side
Valuation
| Metric | CTNM | TKNO |
|---|---|---|
| P/S ratio | N/A | 10.74 |
| P/B ratio | 1.99 | 7.49 |
Profitability
| Metric | CTNM | TKNO |
|---|---|---|
| Gross margin | 0.00% | 33.94% |
| Operating margin | 0.00% | -36.19% |
| Net margin | 0.00% | -38.37% |
| ROE | -24.02% | -26.79% |
| ROIC | -27.22% | -17.77% |
Growth (annualized)
| Metric | CTNM | TKNO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.65% |
| Total return CAGR (5Y) | N/A | -18.15% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.